about
"Stormy waters ahead": global emergence of carbapenemasesGlobal Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection MethodsLaboratory Detection and Clinical Implication of Oxacillinase-48 like Carbapenemase: The Hidden ThreatDissemination of Antimicrobial Resistance in Microbial Ecosystems through Horizontal Gene TransferCarbapenem resistance: overview of the problem and future perspectivesDissemination of carbapenemases producing Gram negative bacteria in the Middle EastEpidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countriesStructural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by HalogensResistance mechanismsTreatment Options for Carbapenem-Resistant Enterobacteriaceae InfectionsClass D β-lactamases: a reappraisal after five decadesCharacterization of Carbapenem-Resistant Enterobacteriaceae with High Rate of Autochthonous Transmission in the Arabian PeninsulaSurveillance of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Dairy Cattle Farms in the Nile Delta, EgyptCarbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria.Emergence of OXA-48-Producing Klebsiella pneumoniae in TaiwanOccurrence of OXA-48 Carbapenemase and Other β-Lactamase Genes in ESBL-Producing Multidrug Resistant Escherichia coli from Dogs and Cats in the United States, 2009-2013.Outbreak of OXA-48-Producing Klebsiella pneumoniae Involving a Sequence Type 101 Clone in Batna University Hospital, AlgeriaClonal dissemination of OXA-232 carbapenenase-producing Klebsiella pneumoniae in neonates.First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new worldCharacteristics of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae Isolates from rivers and lakes in SwitzerlandOXA-48 carbapenemase-producing Salmonella enterica serovar Kentucky isolate of sequence type 198 in a patient transferred from Libya to Switzerland.New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.Outbreak caused by NDM-1- and RmtB-producing Escherichia coli in BulgariaThe global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignanciesMolecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers.IS1R-mediated plasticity of IncL/M plasmids leads to the insertion of bla OXA-48 into the Escherichia coli Chromosome.Increase in the Prevalence of Carbapenem-Resistant Acinetobacter Isolates and Ampicillin-Resistant Non-Typhoidal Salmonella Species in Korea: A KONSAR Study Conducted in 2011.Carbapenem Resistance among Enterobacter Species in a Tertiary Care Hospital in Central India.Osteomyelitis due to multiple carbapenemase-producing Gram-negative bacteria: The first case report of a GES-13-producing Pseudomonas aeruginosa isolate in Canada.Whole-genome assembly of Klebsiella pneumoniae coproducing NDM-1 and OXA-232 carbapenemases using single-molecule, real-time sequencing.Discovery of bla(OXA-199), a chromosome-based bla(OXA-48)-like variant, in Shewanella xiamenensis.OXA-181-producing Klebsiella pneumoniae establishing in SingaporeWhole genome sequence analysis of the first Australian OXA-48-producing outbreak-associated Klebsiella pneumoniae isolates: the resistome and in vivo evolution.Cluster of Escherichia coli isolates producing a plasmid-mediated OXA-48 β-lactamase in a Spanish hospital in 2012.Detection of OXA-48-type carbapenemase-producing Enterobacteriaceae in diagnostic laboratories can be enhanced by addition of bicarbonates to cultivation media or reaction buffers.Pharmacokinetics and penetration of ceftazidime and avibactam into epithelial lining fluid in thigh- and lung-infected mice.
P2860
Q21131125-CE19CCF5-FE8C-483A-8272-2589899E56C7Q26744583-51688B84-5CCF-4DA2-B84A-0C71572DD025Q26751295-F62FFB94-44F8-46FB-9C70-BC4C4A32CDC1Q26765870-89B52039-F248-4930-A446-220702D7A095Q26767081-B2EFF493-C813-4D84-B5E9-C7B1A8D2EDB7Q26771490-44964524-5726-4854-B024-36BBAFBDC96EQ26827160-A485C566-C551-49D8-8774-D8543E58D2D9Q27700611-A54EDBBA-E7EE-41D7-9B6A-CFD32B77DA86Q28069941-D249BB20-4DB9-47DE-A24F-CAAA9064088DQ28082546-8F3917FA-555B-4C9D-83EF-F5D6C8499849Q28295700-11BF1E23-90D1-4190-875F-B76E1CADBCB9Q28545807-6F3D28B9-96AE-43AE-AC96-96DEB03097ABQ28596830-EF538715-8CF5-439A-953F-DC188511D8B2Q30148824-F9564660-0711-48F3-BCD2-8164B869358CQ30234956-57E69D04-FA78-4153-BAF5-2804FE5019F8Q30234957-E9E335CC-36A0-47B9-B950-5C5250A2200AQ30300020-518C2F62-461E-4AE6-8007-CB656A5CCE94Q30362146-C8555B2F-40EC-4549-B802-6365E7BBFCDCQ30379652-0E80C7B7-29EC-4CEB-924C-F659FFA5CC8AQ30391018-B7D7B66C-897A-4677-B23E-DDC6066967E5Q30393131-8153FD51-2DCB-4351-BE80-496C2E683EBAQ30402313-3B407FB0-4615-4A88-98AC-557E98C8AFE7Q30417939-027AE8A7-E7EF-431C-B946-2DD134A9DCC4Q30427771-0A59F74D-6BBF-4C36-85D6-B82BF4346A17Q33622846-BB3E83E1-6B79-437B-BE3D-8A96B2F0BC2BQ33622976-2F532FC7-EC97-4B60-8797-31AB2AE44BADQ33623014-684B149D-BF3F-4409-88ED-680AE6BF4DEEQ33686940-654FA64B-CC61-4C56-BB77-D05C2A9B31B4Q33797909-7CEFE164-00CB-4AFE-9A67-82C87397EDCAQ33798390-8BA6D9D3-2F31-4A8F-A1BF-8EB9885103BCQ33879489-0F1E4E06-4E98-4B5F-83BD-19F40B75EEA7Q34080525-C901A468-C5A2-4266-BF5F-D18E2CA1C657Q34238419-8961138F-9133-439F-B847-3678693BA358Q34299109-FD0F18F8-800B-442A-886F-C71C8C340F11Q34461151-FE2B8987-5ED7-41E0-AA4F-A2E95D118453Q34572248-062B2B4D-864F-4D30-8D23-01887D9F587FQ34652593-02E95A62-FF41-4DB5-9656-6D2DD61C0508Q35035813-8ABCED3C-3355-4D75-8B57-3A40F50750ADQ35083616-B723F3C7-20EB-4B8E-A824-2FDC20214372Q35168955-3B5FC7DD-6FEE-42DE-A472-153B818540DB
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
OXA-48-like carbapenemases: the phantom menace.
@en
type
label
OXA-48-like carbapenemases: the phantom menace.
@en
prefLabel
OXA-48-like carbapenemases: the phantom menace.
@en
P2860
P356
P1476
OXA-48-like carbapenemases: the phantom menace.
@en
P2093
Anaïs Potron
P2860
P304
P356
10.1093/JAC/DKS121
P407
P577
2012-04-11T00:00:00Z